BioMed Research International

Cytotoxic T Lymphocytes and Vaccine Development


Publishing date
01 Jun 2010
Status
Published
Submission deadline
01 Dec 2009

Lead Editor

1Department of Animal and Avian Sciences, University of Maryland, College Park, MD 20742, USA

2Department of Cellular Biology, University of Georgia, Athens, GA 30602, USA

3Department of Infectious Disease, School of Veterinary Medicine China Agricultural University, Beijing 100094, China


Cytotoxic T Lymphocytes and Vaccine Development

Description

As one of the major players in adaptive immunity, cytotoxic T Lymphocytes (CTLs) play a critical role in the control of many infections and cancers. More importantly, induction of long-lasting functional CTLs has become a goal for the modern vaccination, especially for chronic infectious diseases. However, to achieve this goal, CTLs have to be appropriately activated and programmed. The molecular mechanisms of CTL activation are just starting to be understood and have been shown to be related to antigenic stimulation, expression of distinct costimulatory molecules, and inflammatory cytokines. In addition, provision of these stimuli may differ with distinct infections due to the tissue-specificity of the pathogen, chronicity or persistence of antigen, differences in antigen presentation, and/ or the cytokine milieu. By increasing our overall understanding of how these factors modulate CTL responses, we can design multifaceted vaccines which augment the development of functional, long-lasting memory CTLs in addition to neutralizing antibodies.

We invite authors to present original research articles as well as review articles that will stimulate the continuing efforts in defining the factors involved in CTL activation and the development of immunological memory. We are particularly interested in manuscripts that report the molecular mechanisms required for the development of effector and memory CTLs, CTL responses in specific infections in animals and humans, test different strategies of memory CTL induction, and reports of new assays to evaluate CTL function. Reviews that summarize the results of latest discoveries and their implications on vaccination in economically important animals, the regulation of CTL responses by immune cells such as dendritic cells, CD4 and regulatory cells, as well as molecular mechanisms of CTL killing function are particularly welcome. Potential topics include but are not limited to:

  • Molecular mechanisms of CTL activation and programming
  • Signal transduction for CTL migration
  • Regulation of CTL induction and function by regulatory cells
  • Molecular and epigenetic mechanisms of functional memory T cell development
  • Characterization of CTL responses in infections in animals and humans
  • Novel vaccine approaches for the induction of functional memory CTLs
  • New assays for the evaluation of CTL activation

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jbb/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2010
  • - Article ID 354068
  • - Review Article

Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans

Anastas Pashov | Bejatolah Monzavi-Karbassi | ... | Thomas Kieber-Emmons
  • Special Issue
  • - Volume 2010
  • - Article ID 234540
  • - Research Article

Exploration of the Lysis Mechanisms of Leukaemic Blasts by Chimaeric T-Cells

David Laurin | Virna Marin | ... | Joël Plumas
  • Special Issue
  • - Volume 2010
  • - Article ID 548280
  • - Review Article

A New Insight into Hepatitis C Vaccine Development

Chun I. Yu | Bor-Luen Chiang
  • Special Issue
  • - Volume 2010
  • - Article ID 645213
  • - Research Article

-Glucan Oligosaccharide Enhances T Cells Immune Response Induced by a DNA Vaccine Encoding Hepatitis B Virus Core Antigen

Jing Wang | Shengfu Dong | ... | Di Qu
  • Special Issue
  • - Volume 2010
  • - Article ID 591348
  • - Research Article

Development of Th1 Imprints to rBCG Expressing a Foreign Protein: Implications for Vaccination against HIV-1 and Diverse Influenza Strains

Carl Power | Travis W. Marfleet | ... | Peter Bretscher
  • Special Issue
  • - Volume 2010
  • - Article ID 692097
  • - Review Article

Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience

Knut Liseth | Elisabeth Ersvær | ... | Øystein Bruserud
  • Special Issue
  • - Volume 2010
  • - Article ID 623687
  • - Review Article

RNA Vaccines in Cancer Treatment

Anita Bringmann | Stefanie Andrea Erika Held | ... | Peter Brossart
  • Special Issue
  • - Volume 2010
  • - Article ID 497219
  • - Research Article

Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses

Ling Ye | Zhiyuan Wen | ... | Chinglai Yang
  • Special Issue
  • - Volume 2010
  • - Article ID 279391
  • - Research Article

Maintenance or Emergence of Chronic Phase Secondary Cytotoxic T Lymphocyte Responses after Loss of Acute Phase Immunodominant Responses Does Not Protect SIV-Infected Rhesus Macaques from Disease Progression

M. Shannon Keckler | Vida L. Hodara | ... | Luis D. Giavedoni
  • Special Issue
  • - Volume 2010
  • - Article ID 863985
  • - Review Article

Controlling Influenza by Cytotoxic T-Cells: Calling for Help from Destroyers

Michael Schotsaert | Lorena Itatí Ibañez | ... | Xavier Saelens
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.